Next Article in Journal
Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium
Previous Article in Journal
Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?
 
 
Article

Article Versions Notes

Cancers 2024, 16(3), 495; https://doi.org/10.3390/cancers16030495
Action Date Notes Link
article xml file uploaded 24 January 2024 06:46 CET Original file -
article xml uploaded. 24 January 2024 06:46 CET Update https://www.mdpi.com/2072-6694/16/3/495/xml
article pdf uploaded. 24 January 2024 06:46 CET Version of Record https://www.mdpi.com/2072-6694/16/3/495/pdf
article html file updated 24 January 2024 06:47 CET Original file https://www.mdpi.com/2072-6694/16/3/495/html
Back to TopTop